Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
TechBio_Corp.
|
| gptkbp:awards |
Best New Drug 2022
|
| gptkbp:CEO |
gptkb:John_Doe
|
| gptkbp:clinicalTrials |
Phase 2 Trials
Phase 3 Trials Phase 1 Trials |
| gptkbp:collaborations |
Global_Health_Organization
|
| gptkbp:communityEngagement |
Health Workshops
Scholarship_Program |
| gptkbp:communityOutreach |
Health Education Programs
Health Awareness Campaigns Free Health Screenings Volunteer Days Partnership with Local Clinics |
| gptkbp:employees |
500
|
| gptkbp:financials |
Publicly Traded
|
| gptkbp:founded |
gptkb:Boston,_MA
2001 |
| gptkbp:founder |
Jane_Smith
|
| gptkbp:funding |
$50 million
|
| gptkbp:headCoach |
500
|
| gptkbp:headquarters |
gptkb:New_York,_USA
gptkb:New_York_City |
| https://www.w3.org/2000/01/rdf-schema#label |
BioPharma Inc.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
$100 million in R&D
Venture_Capital_Group |
| gptkbp:keyPeople |
COO - Sarah Brown
CFO_-_Alice_Johnson CMO_-_Emily_Davis CSO_-_Robert_Wilson CTO_-_Mark_Lee |
| gptkbp:market |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:partnerships |
gptkb:University_of_Medicine
gptkb:HealthTech_Innovations Clinical_Trials_Network BioResearch_Labs Health_Systems_Inc. PharmaTech_Solutions |
| gptkbp:patentCitation |
Patent 123456
Patent 789012 |
| gptkbp:products |
Drug A
Drug B |
| gptkbp:researchFocus |
Immunology
Oncology |
| gptkbp:revenue |
$200 million
|
| gptkbp:socialResponsibility |
Community Health Initiative
Environmental_Sustainability_Program |
| gptkbp:stockSymbol |
BIOP
|
| gptkbp:subsidiary |
BioPharma Europe
|
| gptkbp:sustainability |
Carbon Neutral by 2030
Zero Waste by 2025 |
| gptkbp:website |
www.biopharma.com
|